Resultados de la búsqueda 31-40 of 4258 for treatment resistant depression
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...
Authorizaton to Use Clincially Obtained Data for Research · Rare Kidney Stone Consortium Patient Registry · Post Approval Study for Treatment of Drug-resistant ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia. Patients ... treatment (including ...
Monoamine oxidase inhibitors for treatment-resistant depression. In: Managing Treatment-Resistant Depression. Elsevier; 2022. https://www.clinicalkey.com ...
... treatment with mTOR inhibitors sirolimus or everolimus as part of their clinical care. ... Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS ...
Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression: A systematic review focused on the long-term antidepressive effect.
... Treat Subjects with Relapsed or Refractory ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... resistant chronic lymphocytic leukemia.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?